CDKN2A and Patent ductus arteriosus: In contrast to p53, the Retinoblastoma (Rb) tumor suppressor is rarely mutated in PDA, but as a consequence of p16 and p21 loss, CDKs phosphorylate Rb at specific serine residues, rendering it inactive [4].